A randomized phase 3 study of nivolumab or placebo combined with radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma with methylated MGMT promoter: Checkmate 548 Meeting Abstract
| Authors: | Weller, M.; Lim, M.; Idbaih, A.; Steinbach, J.; Finocchiaro, G.; Raval, R.; Ashby, L.; Ansstas, G.; Baehring, J.; Taylor, J.; Honnorat, J.; Petrecca, K.; de Vos, F.; Wick, A.; Sumrall, A.; Roberts, M.; Slepetis, R.; Warad, D.; Lee, M.; Reardon, D.; Omuro, A. |
| Abstract Title: | A randomized phase 3 study of nivolumab or placebo combined with radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma with methylated MGMT promoter: Checkmate 548 |
| Meeting Title: | 26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 23 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2021 Nov 18-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-11-01 |
| Start Page: | vi55 |
| End Page: | vi56 |
| Language: | English |
| ACCESSION: | WOS:000757356200219 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noab196.217 |
| Notes: | Meeting Abstract: CTIM-25 -- Source: Wos |
